Categories
Change Password!
Reset Password!
PVL-positive community-associated MRSA drives recurrent, hard-to-treat skin infections, highlighting the need for integrated surgical, antimicrobial, and decolonization strategies.
A case series from Italy highlights the growing clinical impact of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) producing panton-valentine leukocidin (PVL), underscoring the requisition for aggressive, integrated management strategies.
From healthcare-associated MRSA (HA-MRSA), CA-MRSA has evolved as a genetically distinct lineage. Unlike HA-MRSA, CA-MRSA frequently carries the PVL toxin gene, which is linked with tissue necrosis and severe skin and soft tissue infections (SSTIs) in otherwise healthy people. These infections often spread within households and respond poorly to standard oral antibiotics. The group of researchers investigated a series of difficult-to-treat PVL-positive CA-MRSA cases and evaluated practical management strategies in hospitalized patients.
The study reported 5 consecutive cases of PVL-positive CA-MRSA SSTIs treated at a tertiary infectious diseases center in Palermo, Italy. Cases were confirmed utilizing the Centers for Disease Control and Prevention (CDC) criteria for CA-MRSA, and bacterial detection relied on matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Assessment of antimicrobial susceptibility followed European Committee on Antimicrobial Susceptibility Testing (EUCAST) standards, while polymerase chain reaction assays verified PVL gene presence.
Treatment approaches, encompassing surgical drainage, systemic antibiotic therapy, and comprehensive patient and household decolonization, were systematically documented and analyzed for clinical outcomes. All five patients presented with severe or recurrent SSTIs that showed limited response to standard oral antibiotics. Successful management required prompt surgical drainage combined with systemic antimicrobial therapy. Long-acting lipoglycopeptides, including oritavancin and dalbavancin, were used in cases resistant to conventional treatments and contributed to clinical resolution.
Household screening and decolonization of patients and close contacts were essential to prevent reinfection and intrafamilial spread. The cases highlighted the aggressive nature of PVL-positive CA-MRSA and the need for coordinated, multifaceted treatment strategies. Researchers concluded that PVL-positive CA-MRSA SSTIs require a comprehensive, multifaceted approach for effective management. Clinical resolution was achieved only through a combination of timely surgical drainage, targeted systemic antibiotics, particularly long-acting lipoglycopeptides, and thorough decolonization of patients and household contacts.
Infectious Disease Reports
Difficult-to-Treat Skin and Soft Tissue Infections Caused by Panton-Valentine Leukocidin-Producing Community-Associated Methicillin-Resistant Staphylococcus aureus: A Case Series
Luca Pipitò et al.
Comments (0)